| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a56e82e7ee8111cfcd7565412176b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
| filingDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726a86833b7b4ee4caa9275204e52023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a975ce9fae1206cbbef95c20a1897463 |
| publicationDate |
2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1644349-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising cabbinochreme type compounds |
| abstract |
The invention relates to the use of cannabichromene type compounds and derivatives thereof in the treatment of mood disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202771-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11084770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040932-B2 |
| priorityDate |
2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |